DAWN
Day One Biopharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.53
+0.00%Latest reported
- Last report date
- May 5, 2026
- EPS actual
- -$0.35
- EPS estimate
- -$0.31
- Revenue actual
- —
- Revenue estimate
- $54.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +14.8%
- Revenue beats (12Q)
- 2
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 5, 2026 | -$0.31 | -$0.35 | Miss -12.90% | — |
| Feb 24, 2026 | -$0.17 | -$0.21 | Miss -23.53% | $53.7M |
| Feb 25, 2025 | -$0.35 | -$0.69 | Miss -97.14% | $29.2M |
| Oct 30, 2024 | -$0.41 | $0.38 | Beat 192.68% | $93.8M |
| May 1, 2023 | -$0.60 | -$0.59 | Beat 1.67% | — |
| Mar 6, 2023 | -$0.57 | -$0.56 | Beat 1.75% | — |
| Aug 4, 2022 | -$0.49 | -$0.60 | Miss -22.45% | — |
| May 12, 2022 | -$0.39 | -$0.48 | Miss -23.08% | — |
| Mar 7, 2022 | -$0.36 | -$0.36 | In line | — |
| Aug 10, 2021 | -$0.31 | -$5.04 | Miss -1525.81% | — |
| May 27, 2021 | — | -$0.56 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 5, 2026